• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Divulgando ciencia

Máster en Investigación, Desarrollo, Control e Innovación de Medicamentos

  • Home
  • Presentation
  • Curses
    • 2021/2022
    • 2020/2021
  • Category
    • Biology
    • Biotechnological drugs
    • Chemical drugs
    • Cosmetics
    • Nanotechnology
    • Probiotics
  • Links of interest
  • Privacy Policy
You are here: Home / Archives for Hyaluronic Acid

Design and study of new drugs with possible antitumor activity – Noelia Ruiz Cuevas

8 May, 2022 por Anabel Torrente Leave a Comment

 

CD44 is a membrane receptor found in various types of cells in our body. This receptor binds mainly to hyaluronic acid (HA). The interaction of HA with CD44 induces changes that trigger rapid growth (proliferation) of cancer cells. Inhibition of this interaction could therefore interrupt tumour progression.
There is a specific place (small pocket) in the structure of CD44 in which small molecules could be introduced that would act as inhibitors of tumour activity. The first structures to show inhibitory activity when interacting with this pocket were molecules known as tetrahydroisoquinoline derivatives. However, it is difficult to assess the capacity of these molecules as possible antitumor agents due to their poor solubility. The main objective of this research is therefore to synthesize a series of isoquinoline salts that have good solubility in water, so facilitating the biological evaluation of these molecules.
These molecules are obtained via the reaction of isoquinoline with a chemical compound, the 3,4,5-trimethoxybenzyl group, and the introduction of different substituents in its structure, specifically in a structure known as an aromatic ring. These substitutions enable us to study the structure-activity relationship and the effect on the binding of the molecules to the aforementioned pocket in CD44.

Keywords: cancer; inhibitors; hyaluronic acid; CD44; isoquinoline.

Directed by: Olga Cruz López

Filed Under: 2021/2022, Chemical drugs. Tagged With: Cáncer, CD44, Hyaluronic Acid, Inhibitors, isoquinoline.

Designing new drugs for the treatment of cancer – Laura Erviti Marticorena

7 May, 2022 por Anabel Torrente Leave a Comment

 

CD44 is a protein that is found on the surface of human cells. It interacts with another protein, hyaluronic acid (HA), causing normal cells to become tumour cells, so enabling tumour development, metastasis and resistance to drug treatment. HA-CD44 interaction is therefore an interesting pharmacological target in cancer therapy.
The main objective of this project is the design, synthesis, and biological evaluation of inhibitors of HA-CD44 interaction, known as derivatives of 1,2,3,4-tetrahydroisoquinoline (THIQ). These molecules act as antitumor agents because they bind to CD44 in a place close to where HA binds, thus inhibiting HA-CD44 interaction. To this end, in this project we study the influence of small variations in the structure of 1,2,3,4-tetrahydroisoquinoline on the inhibition of the HA-CD44 interaction.

Keywords: cancer; inhibitors; hyaluronic acid; CD44, isoquinoline.

Directed by: Ana Conejo García

Filed Under: 2021/2022, Chemical drugs. Tagged With: Cáncer, CD44, Hyaluronic Acid, Inhibitors, isoquinoline.

Synthesis, purification and structural determination of isoquinolin-5-ol derivatives as antitumor agents – Soledad Romero Tamudo

1 May, 2022 por Anabel Torrente Leave a Comment

Cancer is a disease that begins when a cancerous cell manages to evade the main regulatory mechanisms of the cell cycle and begins to proliferate uncontrollably. It is one of the leading causes of death worldwide, so the search for new therapies is essential.
CD44 is a glycoprotein whose increased expression makes tumors more resistant to cancer treatments. Its ligand is hyaluronic acid (HA) and after binding, signaling cascades are activated that contribute to increased cell proliferation, migration and tissue invasion.
Tetrahydroisoquinoline (THIQ) inhibits binding between CD44 and HA. With this in mind, in this Master’s Thesis, we propose the synthesis of 10 isoquinolin-5-ol derivatives. We will then assess the capacity of these derivatives to act as antitumor agents by inhibiting binding between CD44 and HA.

Keywords: Cancer; CD44; Hyaluronic Acid; Tetrahydroisoquinoline; Inhibitors.

Directed by: María Dora Carrión Peregrina

Filed Under: 2020/2021, Chemical drugs. Tagged With: Cáncer, CD44, Hyaluronic Acid, Inhibitors, Tetrahydroisoquinoline

Primary Sidebar

  • EnglishEnglish
  • EspañolEspañol

Tweets

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Universidad de Granada
blogsUgr
C.S.I.R.C. · Plataformas webs corporativas
Log in

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Divulgando ciencia
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy